Cholinesterase inhibitors for Alzheimer's disease
41 results
1 - 41
Cholinesterase inhibitors for Alzheimer's disease
Cholinesterase inhibitors for Alzheimer’s disease - Combination therapy with cholinesterase inhibitors and memantine for Alzheimer’s disease
- Velnacrine for Alzheimer's disease: Cochrane systematic review
- Metrifonate for Alzheimer's disease: Cochrane systematic review
- Alzheimer’s disease
- Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review
- Cholinesterase inhibitors for Parkinson's disease dementia
- Cholinesterase inhibitors for mild cognitive impairment
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
- Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
Some drugs slightly improve cognition in people with dementia; effects on behavioral or psychological symptoms remain unclear- Rivastigmine for Alzheimer's disease
- Donepezil for dementia due to Alzheimer's disease
- Memantine for Alzheimer’s disease
- Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis
- Memantine for dementia
- Cognitive enhancers significantly improve Mini-Mental State Examination score in patients with Alzheimer's dementia
- Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people
- Huperzine A for Alzheimer's disease: Cochrane systematic review
- Galantamine for vascular cognitive impairment
- Donepezil for vascular cognitive impairment: Cochrane systematic review
- Rivastigmine for vascular cognitive impairment
- Galantamine for Alzheimer’s disease
- Pharmacological interventions for apathy in Alzheimer's disease
- Folic acid with or without vitamin B12 for cognition and dementia
- Pharmacological interventions for the treatment of delirium in critically ill adults
- Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting
- Antidepressants for agitation and psychosis in dementia: Cochrane systematic review